Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.

Abstract:

:Initiation of DNA replication requires the function of MCM gene products, which participate in ensuring that DNA replication occurs only once in the cell cycle. Expression of all mammalian genes of the MCM family is induced by growth stimulation, unlike yeast, and the mRNA levels peak at G1/S boundary. In this study, we examined the transcriptional activities of isolated human MCM gene promoters. Human MCM5 and MCM6 promoters with mutation in the E2F sites failed in promoter regulation following serum stimulation and exogenous E2F expression. In addition, we identified a novel E2F-like sequence in human MCM6 promoter which cooperates with the authentic E2F sites in E2F-dependent regulation. Forced expression of E2F1 could induce expression of all members of the endogenous MCM genes in rat embryonal fibroblast REF52 cells. Our results demonstrated that the growth-regulated expression of mammalian MCM5 and MCM6 genes, and presumably other MCM members, is primarily regulated by E2F through binding to multiple E2F sites in the promoters.

journal_name

Oncogene

journal_title

Oncogene

authors

Ohtani K,Iwanaga R,Nakamura M,Ikeda M,Yabuta N,Tsuruga H,Nojima H

doi

10.1038/sj.onc.1202544

subject

Has Abstract

pub_date

1999-04-08 00:00:00

pages

2299-309

issue

14

eissn

0950-9232

issn

1476-5594

journal_volume

18

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists.

    abstract::Lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) are extracellular lipid mediators that signal through distinct members of the Edg/LP subfamily of G protein-coupled receptors (GPCRs). LPA and S1P receptors are expressed in almost every cell type and can couple to multiple G proteins (G(i), G(q) and G(12/1...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1204187

    authors: Kranenburg O,Moolenaar WH

    更新日期:2001-03-26 00:00:00

  • Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells.

    abstract::We evaluated the effect of nitric oxide (NO) on vascular endothelial growth factor (VEGF) gene expression in human A-172 glioblastoma cells and human HepG2 hepatocellular carcinoma cells. The mRNA level of VEGF increased in response to S-Nitroso-N-acetyl-D,L-penicillamine (SNAP) in both cell lines, and increased in mR...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201201

    authors: Chin K,Kurashima Y,Ogura T,Tajiri H,Yoshida S,Esumi H

    更新日期:1997-07-24 00:00:00

  • High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.

    abstract::We analysed 31 non-glioblastoma astrocytomas for alterations in p53 protein expression and for mutations in the p53 gene. Immunohistochemistry detected p53 protein accumulation in 71% (five of seven) of juvenile pilocytic astrocytomas (WHO grade I), 63% (five of eight) of astrocytomas (WHO grade II), and 63% (10 of 16...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Lang FF,Miller DC,Pisharody S,Koslow M,Newcomb EW

    更新日期:1994-03-01 00:00:00

  • The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and malignant human tissues and may function as a tumor suppressor.

    abstract::Topors was identified recently as a human protein that binds to topoisomerase I and p53. Topors contains a highly conserved RING domain and localizes in promyelocytic leukemia nuclear bodies. Relatively little is known regarding topors expression patterns or function. We now demonstrate that topors mRNA and protein ar...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207700

    authors: Saleem A,Dutta J,Malegaonkar D,Rasheed F,Rasheed Z,Rajendra R,Marshall H,Luo M,Li H,Rubin EH

    更新日期:2004-07-08 00:00:00

  • Identification of multiple SNT-binding sites on NPM-ALK oncoprotein and their involvement in cell transformation.

    abstract::The t(2;5) chromosomal translocation occurs in anaplastic large-cell lymphoma arising from activated T lymphocytes. This genomic rearrangement generates the nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) oncoprotein that is a chimeric protein consisting of parts of the nuclear protein NPM and ALK receptor protei...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210095

    authors: Chikamori M,Fujimoto J,Tokai-Nishizumi N,Yamamoto T

    更新日期:2007-05-03 00:00:00

  • Concurrent activation of c-myc and inactivation of bcl-2 by chromosomal translocation in a lymphoblastic lymphoma cell line.

    abstract::We have characterized a chromosomal translocation in a cell line (SU-DUL5) established from a patient with lymphoblastic lymphoma in which the c-myc gene on chromosome 8 was juxtaposed to a t(14;18). Cytogenetic analysis of this cell line showed 14q+, 18q-, and 8p+q+ marker chromosomes in the absence of t(14;18). Geno...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kiem HP,Nourse J,Saltman DL,Blume KG,Cleary ML

    更新日期:1990-12-01 00:00:00

  • Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.

    abstract::beta-catenin activation, and subsequent upregulation of Wnt-signaling, is an important event in the development of certain human and rodent cancers. Recently, mutations in the beta-catenin gene in the region of the serine-threonine glycogen kinase (GSK)-3beta phosphorylation target sites have been identified in hepato...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202858

    authors: Devereux TR,Anna CH,Foley JF,White CM,Sills RC,Barrett JC

    更新日期:1999-08-19 00:00:00

  • Cytokinesis failure due to derailed integrin traffic induces aneuploidy and oncogenic transformation in vitro and in vivo.

    abstract::Aneuploidy is frequently detected in solid tumors but the mechanisms regulating the generation of aneuploidy and their relevance in cancer initiation remain under debate and are incompletely characterized. Spatial and temporal regulation of integrin traffic is critical for cell migration and cytokinesis. Impaired inte...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.527

    authors: Högnäs G,Tuomi S,Veltel S,Mattila E,Murumägi A,Edgren H,Kallioniemi O,Ivaska J

    更新日期:2012-08-02 00:00:00

  • Modulation of Nr-13 antideath activity by peptide aptamers.

    abstract::Tumor cells are characterized by deregulated proliferation and resistance to proapoptotic stimuli. The Bcl-2 family of antiapoptotic proteins is overexpressed in a large number of chemoresistant tumors. Downregulation or inhibition of antiapoptotic proteins might result in the sensitization of cancer cells to chemothe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209832

    authors: Nouvion AL,Thibaut J,Lohez OD,Venet S,Colas P,Gillet G,Lalle P

    更新日期:2007-02-01 00:00:00

  • The relationship among p53 oligomer formation, structure and transcriptional activity using a comprehensive missense mutation library.

    abstract::Tumor suppressor p53 forms a homo-tetramer through its COOH-terminal oligomerization domain and acts as a sequence-specific transcription factor. We have analysed the interrelation among the transcriptional activities, the structure and the cancer-related mutations in the oligomerization domain by using a comprehensiv...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208839

    authors: Kawaguchi T,Kato S,Otsuka K,Watanabe G,Kumabe T,Tominaga T,Yoshimoto T,Ishioka C

    更新日期:2005-10-20 00:00:00

  • Wild-type p53 gene transfer is not detrimental to normal cells in vivo: implications for tumor gene therapy.

    abstract::The p53 oncosuppressor is strictly maintained in an inactive form under normal conditions, while it is post-translationally activated by a variety of stresses, enacting different protective biological functions. Since one critical issue in cancer gene therapy is tumor specificity, we asked whether the tight p53 regula...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207042

    authors: Bossi G,Mazzaro G,Porrello A,Crescenzi M,Soddu S,Sacchi A

    更新日期:2004-01-15 00:00:00

  • Evaluation of novel cell cycle inhibitors in mantle cell lymphoma.

    abstract::Signature abnormalities in the cell cycle and apoptotic pathway have been identified in mantle cell lymphoma (MCL), affording the opportunity to develop targeted therapies. In this study, we tested a novel class of kinase inhibitors, styryl sulfones, which differ from prior cell cycle inhibitors in that they are not r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210350

    authors: Park IW,Reddy MV,Reddy EP,Groopman JE

    更新日期:2007-08-16 00:00:00

  • R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation.

    abstract::Within the superfamily of ras-related GTP-binding proteins, only ras itself has been shown to act as an oncogene. Seven other proteins, however, have greater than 50% amino acid identity to ras and one of them, rap1A, has been shown to interact with the ras GTPase activating protein, ras-GAP, and to inhibit ras functi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Rey I,Taylor-Harris P,van Erp H,Hall A

    更新日期:1994-03-01 00:00:00

  • Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer.

    abstract::O6-methylguanine-DNA methyltransferase (MGMT) repairs the cytotoxic and mutagenic O6-alkylguanine produced by alkylating agents such as chemotherapeutic agents and mutagens. Recent studies have shown that in a subset of tumors, MGMT expression is inversely linked to hypermethylation of the CpG island in the promoter r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207183

    authors: Nakagawachi T,Soejima H,Urano T,Zhao W,Higashimoto K,Satoh Y,Matsukura S,Kudo S,Kitajima Y,Harada H,Furukawa K,Matsuzaki H,Emi M,Nakabeppu Y,Miyazaki K,Sekiguchi M,Mukai T

    更新日期:2003-12-04 00:00:00

  • A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity.

    abstract::Bcl-2 and Bcl-XL serve as critical inhibitors of apoptosis triggered by a broad range of stimuli, mainly acting on the mitochondria. We identified two members of the reticulon (RTN) family as Bcl-XL binding proteins, i.e., NSP-C (RTN1-C) and a new family member, RTN-XS, both of which did not belong to the Bcl-2 family...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203948

    authors: Tagami S,Eguchi Y,Kinoshita M,Takeda M,Tsujimoto Y

    更新日期:2000-11-23 00:00:00

  • Mimicking the BH3 domain to kill cancer cells.

    abstract::Cancer cells show deviant behavior that induces apoptotic signaling. To survive, cancer cells typically acquire changes enabling evasion of death signals. One way they do this is by increasing the expression of anti-apoptotic BCL-2 proteins. Anti-apoptotic BCL-2 family proteins antagonize death signaling by forming he...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2009.52

    authors: Ni Chonghaile T,Letai A

    更新日期:2008-12-01 00:00:00

  • P63 regulates tubular formation via epithelial-to-mesenchymal transition.

    abstract::P63, a p53 family member, is expressed as TA and ΔN isoforms. Interestingly, both TAp63 and ΔNp63 are transcription factors, and regulate both common and distinct sets of target genes. p63 is required for survival of some epithelial cell lineages, and lack of p63 leads to loss of epidermis and other epithelia in human...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.101

    authors: Zhang Y,Yan W,Chen X

    更新日期:2014-03-20 00:00:00

  • Dinucleotide repeats negatively modulate the promoter activity of Cyr61 and is unstable in hepatocellular carcinoma patients.

    abstract::Cyr61 is a secreted, cysteine-rich, heparin-binding protein that mediates diverse functions including extracellular matrix formation, differentiation, cell proliferation, adhesion, migration, survival, as well as angiogenesis and tumorigenesis. In this study, we found that Cyr61 gene expression is significantly downre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208550

    authors: Wang B,Ren J,Ooi LL,Chong SS,Lee CG

    更新日期:2005-06-02 00:00:00

  • A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma.

    abstract::Abnormalities of the p53 tumour suppressor gene occur in many types of cancer including approximately 60% of colorectal carcinomas. This study investigates in 47 colorectal carcinomas the relationship between stabilised p53 protein detected by immunocytochemistry (ICC), and p53 mutation. 27 cases stained positively wi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Cripps KJ,Purdie CA,Carder PJ,White S,Komine K,Bird CC,Wyllie AH

    更新日期:1994-09-01 00:00:00

  • Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1.

    abstract::In lung cancer, frequent loss of one allele of chromosome 3p is seen in both small cell lung cancer and non-small cell lung cancer (NSCLC), providing evidence of tumor suppressor genes (TSGs) in this chromosomal region. The mechanism of Fus1 tumor suppressor activity is unknown. We have found that a Fus1 peptide inhib...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210500

    authors: Lin J,Sun T,Ji L,Deng W,Roth J,Minna J,Arlinghaus R

    更新日期:2007-10-25 00:00:00

  • MicroRNA dysregulation in gastric cancer: a new player enters the game.

    abstract::Gastric carcinogenesis is a multistep process involving genetic and epigenetic alteration of protein-coding proto-oncogenes and tumor-suppressor genes. Recent discoveries have shed new light on the involvement of a class of noncoding RNA known as microRNA (miRNA) in gastric cancer. A substantial number of miRNAs show ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.352

    authors: Wu WK,Lee CW,Cho CH,Fan D,Wu K,Yu J,Sung JJ

    更新日期:2010-10-28 00:00:00

  • HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation.

    abstract::It has recently been shown that the high-risk human papillomavirus (HPV) E6 proteins can target the PDZ-domain containing proteins, Dlg, MUPP-1, MAGI-1 and hScrib for proteasome-mediated degradation. However, the E6 proteins from HPV-16 and HPV-18 (the two most common high-risk virus types) differ in their ability to ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204719

    authors: Thomas M,Glaunsinger B,Pim D,Javier R,Banks L

    更新日期:2001-09-06 00:00:00

  • Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.

    abstract::The C-type lectin domain containing group 14 family members CLEC14A and CD93 are proteins expressed by endothelium and are implicated in tumour angiogenesis. CD248 (alternatively known as endosialin or tumour endothelial marker-1) is also a member of this family and is expressed by tumour-associated fibroblasts and pe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.214

    authors: Khan KA,Naylor AJ,Khan A,Noy PJ,Mambretti M,Lodhia P,Athwal J,Korzystka A,Buckley CD,Willcox BE,Mohammed F,Bicknell R

    更新日期:2017-11-02 00:00:00

  • Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.

    abstract::Ovarian cancer (OvCa) is characterized by widespread and rapid metastasis in the peritoneal cavity. Visceral adipocytes promote this process by providing fatty acids (FAs) for tumour growth. However, the exact mechanism of FA transfer from adipocytes to cancer cells remains unknown. This study shows that OvCa cells co...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-017-0093-z

    authors: Ladanyi A,Mukherjee A,Kenny HA,Johnson A,Mitra AK,Sundaresan S,Nieman KM,Pascual G,Benitah SA,Montag A,Yamada SD,Abumrad NA,Lengyel E

    更新日期:2018-04-01 00:00:00

  • Survivin, versatile modulation of cell division and apoptosis in cancer.

    abstract::Survivin is a member of the inhibitor of apoptosis (IAP) gene family that has attracted attention from several viewpoints of basic and translational research. Its cell cycle-regulated expression at mitosis and association with the mitotic apparatus have been of interest to cell biologists studying faithful segregation...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1207113

    authors: Altieri DC

    更新日期:2003-11-24 00:00:00

  • TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.

    abstract::Metastatic growth in breast cancer (BC) has been proposed as an exclusive property of cancer stem cells (CSCs). However, formal proof of their identity as cells of origin of recurrences at distant sites and the molecular events that may contribute to tumor cell dissemination and metastasis development are yet to be el...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.5

    authors: Bartucci M,Dattilo R,Moriconi C,Pagliuca A,Mottolese M,Federici G,Benedetto AD,Todaro M,Stassi G,Sperati F,Amabile MI,Pilozzi E,Patrizii M,Biffoni M,Maugeri-Saccà M,Piccolo S,De Maria R

    更新日期:2015-02-05 00:00:00

  • Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.

    abstract::The hypoxia-inducible factor 1 (HIF-1) plays a critical role for tumour adaptation to microenvironmental hypoxia, and represents an appealing chemotherapeutic target. Silibinin is a nontoxic flavonoid reported to exhibit anticancer properties. However, the mechanisms by which silibinin inhibits tumour growth are not f...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.398

    authors: García-Maceira P,Mateo J

    更新日期:2009-01-22 00:00:00

  • AMD1 is required for the maintenance of leukemic stem cells and promotes chronic myeloid leukemic growth.

    abstract::Polyamines are critical elements in mammals, but it remains unknown whether adenosyl methionine decarboxylase (AMD1), a rate-limiting enzyme in polyamine synthesis, is required for myeloid leukemia. Here, we found that leukemic stem cells (LSCs) were highly differentiated, and leukemia progression was severely impaire...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01547-x

    authors: Sari IN,Yang YG,Wijaya YT,Jun N,Lee S,Kim KS,Bajaj J,Oehler VG,Kim SH,Choi SY,Park SH,Kim DW,Reya T,Han J,Kwon HY

    更新日期:2021-01-01 00:00:00

  • The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression.

    abstract::Thrombospondin-1 (TSP-1) is an endogenous inhibitor of angiogenesis whose expression suppresses tumor growth in vivo. Like many angiogenesis-related genes, TSP-1 expression is tightly controlled by various mechanisms, but there is little data regarding the contribution of post-transcriptional processing to this regula...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.464

    authors: Doçi CL,Zhou G,Lingen MW

    更新日期:2013-09-12 00:00:00

  • FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease.

    abstract::Identification of prostate cancers at high risk of progression is difficult and a better understanding of how peptide growth factors influence cellular function might be useful. Fibroblast growth factors (FGFs) have been implicated in prostate cancer development. FGF8 was identified in the Shionogi mouse mammary carci...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202624

    authors: Dorkin TJ,Robinson MC,Marsh C,Bjartell A,Neal DE,Leung HY

    更新日期:1999-04-29 00:00:00